CUSIP: 16961L106
Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
43,376,060
-
Share change
-
+11,688,080
-
Total reported value
-
$707,398,633
-
Price per share
-
$16.31
-
Number of holders
-
100
-
Value change
-
+$191,047,351
-
Number of buys
-
67
-
Number of sells
-
24
Quarterly Holders Quick Answers
What is CUSIP 16961L106?
CUSIP 16961L106 identifies KDNY - CHINOOK THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2022
-
Previous quarter:
Q3 2021
Recent filing periods for CUSIP 16961L106:
Institutional Holders of CHINOOK THERAPEUTICS INC - COM (KDNY) as of Q4 2021
As of 31 Dec 2021,
CHINOOK THERAPEUTICS INC - COM (KDNY) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,376,060 shares.
The largest 10 holders included
Samsara BioCapital, LLC, BlackRock Inc., Deep Track Capital, LP, FRAZIER MANAGEMENT LLC, Point72 Asset Management, L.P., BAKER BROS. ADVISORS LP, BVF INC/IL, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, and STATE STREET CORP.
This page lists
100
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.